Human Molecular Genetics, Vol 7, 1893-1900, Copyright © 1998 by Oxford University Press
R Kumar-Singh and DB Farber
First (DeltaE1/E3) and second (DeltaE1+DeltaE2/E3/E4) generation adenovirus
(Ad) vectors have been shown previously to be of limited use in the
treatment of human genetic diseases due to the induction of a host
cytotoxic T-cell mediated immune response against virally expressed genes.
In addition, a limited cloning capacity of approximately 8 kb does not
cater for the incorporation of large upstream sequences essential for
regulated tissue-specific expression or inclusion of multiple
gene-expression cassettes. In this study we have exploited our recently
developed Ad-based vector, the encapsidated adenovirus mini-chromosome
(EAM) from which all of the viral genes have been deleted. EAMs contain
only the inverted terminal repeats required for replication and five cis
-acting Ad encapsidation signals necessary for packaging. We have shown
previously that EAMs can efficiently transduce a variety of cell types in
vitro. In this study we demonstrate that EAMs can transduce and rescue
cells from the neurosensory retina in vivo. EAM-mediated delivery of the
beta subunit of cyclic GMP phosphodiesterase (PDE) cDNA to mice affected
with retinal degeneration (rd) allows prolonged transgene expression and
rescue of rod photoreceptor cells. RT-PCR analysis from the injected retina
indicates that transgene products are present for at least 18 weeks
post-injection. Both the alpha and beta subunits of PDE could be detected
up to 90 days postnatal in EAM-injected rd retina by western analysis. A
maximal PDE activity of 150 nm/min/mg was detected at 33 days postnatal.
Examination of outer nuclear thickness showed significant differences up to
12 weeks post-injection. These results demonstrate an improved level of
rescue over first-generation adenoviral vectors and suggest the possibility
of successful EAM- mediated treatment of some retinal diseases in humans.
ARTICLES
Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration
Jules Stein Eye Institute, School of Medicine and Molecular Biology Institute, UCLA, 100 Stein Plaza, Room B243, Los Angeles, CA 90095- 7008, USA. rajendra@ucla.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Gao and S. Brimijoin Lasting Reduction of Cocaine Action in Neostriatum-- A Hydrolase Gene Therapy Approach J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 449 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Tan, A. J. Smith, B. Pawlyk, X. Xu, X. Liu, J. B. Bainbridge, M. Basche, J. McIntosh, H. V. Tran, A. Nathwani, et al. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors Hum. Mol. Genet., June 15, 2009; 18(12): 2099 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Davis, J. Tosi, K. M. Janisch, J. M. Kasanuki, N.-K. Wang, J. Kong, I. Tsui, M. Cilluffo, M. L. Woodruff, G. L. Fain, et al. Functional Rescue of Degenerating Photoreceptors in Mice Homozygous for a Hypomorphic cGMP Phosphodiesterase 6 b Allele (Pde6bH620Q) Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5067 - 5076. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-j. Pang, S. L. Boye, A. Kumar, A. Dinculescu, W. Deng, J. Li, Q. Li, A. Rani, T. C. Foster, B. Chang, et al. AAV-Mediated Gene Therapy for Retinal Degeneration in the rd10 Mouse Containing a Recessive PDE{beta} Mutation Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4278 - 4283. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walia, G. A. Fishman, D. P. Edward, and M. Lindeman Retinal Nerve Fiber Layer Defects in RP Patients Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4748 - 4752. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Adriaansen, M. J. B. M. Vervoordeldonk, and P. P. Tak Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes Rheumatology, June 1, 2006; 45(6): 656 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schiedner, S. Hertel, M. Johnston, V. Biermann, V. Dries, and S. Kochanek Variables Affecting In Vivo Performance of High-Capacity Adenovirus Vectors J. Virol., February 15, 2002; 76(4): 1600 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M B Reichel, J Bainbridge, D Baker, A J Thrasher, S S Bhattacharya, and R R Ali An immune response after intraocular administration of an adenoviral vector containing a {beta} galactosidase reporter gene slows retinal degeneration in the rd mouse Br J Ophthalmol, March 1, 2001; 85(3): 341 - 344. [Abstract] [Full Text] |
||||
![]() |
S. B. Ogueta, A. Di Polo, J. G. Flannery, C. K. Yamashita, and D. B. Farber The Human cGMP-PDE {beta}-Subunit Promoter Region Directs Expression of the Gene to Mouse Photoreceptors Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4059 - 4063. [Abstract] [Full Text] |
||||
![]() |
M. M. LaVail, D. Yasumura, M. T. Matthes, K. A. Drenser, J. G. Flannery, A. S. Lewin, and W. W. Hauswirth Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy PNAS, September 22, 2000; (2000) 210319397. [Abstract] [Full Text] |
||||
![]() |
W. W. Hauswirth and L. Beaufrere Ocular Gene Therapy: Quo Vadis? Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2821 - 2826. [Full Text] |
||||
![]() |
D. S. Steinwaerder, C. A. Carlson, and A. Lieber Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination between Inverted Repeats J. Virol., November 1, 1999; 73(11): 9303 - 9313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lieber, D. S. Steinwaerder, C. A. Carlson, and M. A. Kay Integrating Adenovirus-Adeno-Associated Virus Hybrid Vectors Devoid of All Viral Genes J. Virol., November 1, 1999; 73(11): 9314 - 9324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nusinowitz, W. H. Ridder III, and J. R. Heckenlively Rod Multifocal Electroretinograms in Mice Invest. Ophthalmol. Vis. Sci., November 1, 1999; 40(12): 2848 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morral, W. O'Neal, K. Rice, M. Leland, J. Kaplan, P. A. Piedra, H. Zhou, R. J. Parks, R. Velji, E. Aguilar-Cordova, et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons PNAS, October 26, 1999; 96(22): 12816 - 12821. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Takahashi, H. Miyoshi, I. M. Verma, and F. H. Gage Rescue from Photoreceptor Degeneration in the rd Mouse by Human Immunodeficiency Virus Vector-Mediated Gene Transfer J. Virol., September 1, 1999; 73(9): 7812 - 7816. [Abstract] [Full Text] |
||||
![]() |
M. M. LaVail, D. Yasumura, M. T. Matthes, K. A. Drenser, J. G. Flannery, A. S. Lewin, and W. W. Hauswirth Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy PNAS, October 10, 2000; 97(21): 11488 - 11493. [Abstract] [Full Text] [PDF] |
||||






